Funder: The Mark Foundation for Cancer Research
Due Dates (Anticipated): May 2026 (Letter of Intent) | July 2026 (Full Application)
Funding Amounts: $250,000/year for 3 years (total $750,000; indirect costs capped at 10% of direct costs, included in total)
Summary: Supports early career investigators pursuing innovative, high-impact, high-risk cancer research projects distinct from their current work.
Key Information: Co-investigators not permitted; U.S. or Canadian non-profit academic appointment required.